1
|
Barbero M, San Antonio B, Alonso L, Molnar V, Alonso B, Rubio G, Abdallah N. ERAS program effects on opioid sparing and functional recovery. Clin Nutr ESPEN 2022. [DOI: 10.1016/j.clnesp.2022.06.058] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
2
|
Manjón JV, Romero JE, Vivo-Hernando R, Rubio G, Aparici F, de la Iglesia-Vaya M, Coupé P. vol2Brain: A New Online Pipeline for Whole Brain MRI Analysis. Front Neuroinform 2022; 16:862805. [PMID: 35685943 PMCID: PMC9171328 DOI: 10.3389/fninf.2022.862805] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2022] [Accepted: 04/07/2022] [Indexed: 11/13/2022] Open
Abstract
Automatic and reliable quantitative tools for MR brain image analysis are a very valuable resource for both clinical and research environments. In the past few years, this field has experienced many advances with successful techniques based on label fusion and more recently deep learning. However, few of them have been specifically designed to provide a dense anatomical labeling at the multiscale level and to deal with brain anatomical alterations such as white matter lesions (WML). In this work, we present a fully automatic pipeline (vol2Brain) for whole brain segmentation and analysis, which densely labels (N > 100) the brain while being robust to the presence of WML. This new pipeline is an evolution of our previous volBrain pipeline that extends significantly the number of regions that can be analyzed. Our proposed method is based on a fast and multiscale multi-atlas label fusion technology with systematic error correction able to provide accurate volumetric information in a few minutes. We have deployed our new pipeline within our platform volBrain (www.volbrain.upv.es), which has been already demonstrated to be an efficient and effective way to share our technology with the users worldwide.
Collapse
Affiliation(s)
- José V. Manjón
- Instituto de Aplicaciones de las Tecnologías de la Información y de las Comunicaciones Avanzadas (ITACA), Universitat Politècnica de València, Valencia, Spain
- *Correspondence: José V. Manjón
| | - José E. Romero
- Instituto de Aplicaciones de las Tecnologías de la Información y de las Comunicaciones Avanzadas (ITACA), Universitat Politècnica de València, Valencia, Spain
| | - Roberto Vivo-Hernando
- Instituto de Automática e Informática Industrial, Universitat Politècnica de València, Valencia, Spain
| | - Gregorio Rubio
- Departamento de Matemática Aplicada, Universitat Politècnica de València, Valencia, Spain
| | - Fernando Aparici
- Área de Imagen Medica, Hospital Universitario y Politécnico La Fe, Valencia, Spain
| | - Mariam de la Iglesia-Vaya
- Unidad Mixta de Imagen Biomédica FISABIO-CIPF, Fundación Para el Fomento de la Investigación Sanitario y Biomédica de la Comunidad Valenciana, Valencia, Spain
- Centro de Investigación Biomédica en Red de Salud Mental, ISC III, València, Spain
| | - Pierrick Coupé
- Centre National de la Recherche Scientifique, Univ. Bordeaux, Bordeaux INP, Laboratoire Bordelais de Recherche en Informatique, UMR5800, PICTURA, Talence, France
| |
Collapse
|
3
|
Letelier H, Rubio G, Guillen Y, Yañez R, Herrera C, Mendez C. PO-1390 SBRT in all-risk prostate cancer patients, first results from a chilean center with Halcyon linac. Radiother Oncol 2022. [DOI: 10.1016/s0167-8140(22)03354-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
4
|
Aguiar C, Araujo F, Rubio G, Carcedo D, Abreu-Oliveira TP, Paz S, Castellano JM, Fuster V. Cost-effectiveness of the CNIC-polypill strategy for the secondary prevention of CV disease in male and female patients with established coronary heart disease based on improved risk factor control. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.2552] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
The burden of CV disease is a health and economic challenge to societies that is expected to grow in future years due to an increased prevalence in CV risk factors. Adequate management and appropriate therapy positively modify risk factors and, consequently, improve outcomes and cost-effectiveness of care. The CNIC-polypill has demonstrated in real-life, clinical effectiveness studies, its superiority over monocomponents in improving the lipidic parameters and in reduction of blood pressure in secondary CV prevention patients.
Purpose
To assess the cost-effectiveness of the CNIC-polypill (acetylsalicylic acid 100mg, atorvastatin 20/40mg, ramipril 2.5/5/10mg) compared to usual care with individual monocomponents for the secondary prevention of CV events in patients with a history of coronary heart disease (CHD) based on control of CV risk factors.
Methods
A Markov cost-effectiveness model (1-year cycles; 4 health states: stable disease, subsequent CHD, subsequent stroke, death; payer perspective; direct medical costs; lifetime horizon; 4% discount rate) based on changes in TC (10,1% reduction), HDL-c (7.4% increment) and SBP (2.6% reduction) obtained from the NEPTUNO* – a real-life, clinical effectiveness study conducted in Spain – was set for Portugal (base case). The probability of transition between health states was based on the SMART risk equation (S0, t=10= 0.8107). Cost-effectiveness was calculated for a hypothetical population (n=1,000) that replicated the characteristics of the population in the proACS registry, comprised of Portuguese patients with previous CHD. Systematic reviews identified epidemiological, costs, utility and mortality data. Outcomes were costs (€, 2020), life years (LY) and quality adjusted LY (QALY) gained.
Results
In patients with a history of CHD, the incremental cost of the CNIC-polypill strategy reaches €365,527, while preventing 35 recurrent CHD events and 17 subsequent strokes. In women and men with previous CHD, the incremental cost reaches €392,529 and €354,444 respectively while preventing recurrent 47 and 30 CHD events and 19 and 16 subsequent strokes respectively. The ICER is €5,130/LY gained for the overall population, €5,768/LY gained for women and €4,884/LY gained for men. The ICUR is €5,332/QALY gained in total, €5,817/QALY gained for women and €5,137/QALY gained for men. Assuming a willingness-to-pay (WTP) threshold of €30,000/QALY gained, there is 76.1% chances in total, 75.8% in women and 76.9% in men for the CNIC-polypill to be cost-effective and 27.8% chances overall, 27.7% in women and 25.5% in men of it being cost saving compared to usual care.
Conclusion
The CNIC-polypill seems to be a cost-effective strategy in men and women compared to usual care with monocomponents for the secondary prevention of CV disease based on improved control of risk factors. A larger reduction in the number of recurrent events is seen in women compared to men at a slightly higher cost.
Funding Acknowledgement
Type of funding sources: Private company. Main funding source(s): Ferrer International S.A. Base case resultsProbabilistic sensitivity analysis
Collapse
Affiliation(s)
- C Aguiar
- Hospital de Santa Cruz, Serviço de Cardiologia, Carnaxide, Portugal
| | - F Araujo
- Hospital dos Lusiadas, Serviço de Medicina Interna, Lisbon, Portugal
| | - G Rubio
- Ferrer Internacional, Barcelona, Spain
| | | | | | - S Paz
- Smartwriting4u, Benicassim, Spain
| | - J M Castellano
- National Centre for Cardiovascular Research (CNIC), Madrid, Spain
| | - V Fuster
- Icahn School of Medicine at Mount Sinai, New York, United States of America
| |
Collapse
|
5
|
Navarro-Main B, Castaño-León AM, Hilario A, Lagares A, Rubio G, Periañez JA, Rios-Lago M, Inertia Group Collaborators. Apathetic symptoms and white matter integrity after traumatic brain injury. Brain Inj 2021; 35:1043-1053. [PMID: 34357825 DOI: 10.1080/02699052.2021.1953145] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Abstract
PRIMARY OBJECTIVE The aim of the study was twofold. First, to study the relationship among apathy in the long term, initial clinical measures, and standard outcome scores after traumatic brain injury (TBI). Second, to describe white matter integrity correlates of apathy symptoms. RESEARCH DESIGN Correlational study. Methods and Procedures: Correlation and Bayesian networks analyses were performed in a sample of 40 patients with moderate to severe TBI in order to identify the relationship among clinical variables, functionality, and apathy. A diffusion tensor imaging study was developed in 25 participants to describe correlations between fractional anisotropy (FA) measures and apathetic symptoms. MAIN OUTCOMES AND RESULTS Correlation analysis revealed associations between pairs of variables as apathy in the long term and functional score at discharge from hospital. Bayesian network illustrated the relevant role of axonal injury mediating the relationship between apathy and initial clinical variables. FA in the superior longitudinal fasciculus, the inferior longitudinal fasciculus, and the internal capsule were negatively correlated with apathy measures. Widespread brain areas showed positive correlations between FA and apathy. CONCLUSIONS These results highlight the relevance of white matter integrity measures in initial assessment after TBI and its relationship with apathetic manifestations in the chronic phase.
Collapse
Affiliation(s)
- B Navarro-Main
- 12 De Octubre Hospital.,I+12 Investigation Institute, INERTIA Research Group.,Faculty of Psychology, Doctoral School UNED
| | - A M Castaño-León
- 12 De Octubre Hospital.,I+12 Investigation Institute, INERTIA Research Group
| | - A Hilario
- 12 De Octubre Hospital.,I+12 Investigation Institute, INERTIA Research Group
| | - A Lagares
- 12 De Octubre Hospital.,I+12 Investigation Institute, INERTIA Research Group
| | - G Rubio
- 12 De Octubre Hospital.,I+12 Investigation Institute, INERTIA Research Group
| | | | | | | |
Collapse
|
6
|
Rubio G, Araujo F, Aguiar C, Carcedo D, Abreu-Oliveira TP, Paz S, Castellano JM. Cost-effectiveness of a cardiovascular polypill strategy (aspirin, atorvastatin, ramipril) for the secondary prevention of cardiovascular disease based on real life improvement in risk factor control. Eur J Prev Cardiol 2021. [DOI: 10.1093/eurjpc/zwab061.447] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Private company. Main funding source(s): Ferrer Internacional
Background
The cardiovascular (CV) polypill has consistently demonstrated cost-effectives in decreasing the risk of CV disease in patients in secondary prevention. Previous pharmacoeconomic studies addressed improvements in adherence as a driver of health gains. This economic assessment focuses on the implications of improved control of risk factors with the polypill as observed in clinical practice.
Purpose
To assess the cost-effectiveness of a fixed-dose combination polypill (ASA 100mg, atorvastatin 20/40mg, ramipril 2.5/5/10mg) strategy for the secondary prevention of CV and cerebrovascular events in adults with a history of coronary heart disease (CHD) or stroke compared to usual care with monocomponents.
Methods
A Markov cost-effectiveness model (1-year cycles; 4 health states: stable disease, subsequent CHD, subsequent stroke, death; payer perspective; direct medical costs; lifetime horizon; 4% discount rate) based on changes in CV risk factors (total cholesterol, 18.3% reduction; high density lipoprotein cholesterol, 2.1% increment; systolic blood pressure, 11.46% reduction) obtained from a real-life effectiveness study was set for Portugal. The probability of transition between health states was based on the SMART risk equation. Cost-effectiveness was calculated for two cohorts (n = 1,000) of secondary prevention patients with previous CHD or stroke. Systematic reviews, Portuguese registries, mortality tables and official reports were searched to identify effectiveness, epidemiological, costs and utility data. Outcomes were costs (€, 2020) per life year (LY) and Quality Adjusted LY (QALY) gained. One-way (OWA) and probabilistic (PSA) sensitivity analyses tested consistency. Assumptions were validated by experts.
Results
In the CHD cohort, the incremental cost-effectiveness ratio for the polypill strategy (ICER) is 2,402 €/LY and the incremental cost-utility ratio (ICUR) is 2,328 €/QALY. Incremental cost reaches 278,927 € (polypill, 13,198,506 €; monocomponents: 12,919,579 €) with less subsequent CV events (552.31 vs 641.88) and CV deaths (102.4 vs 118.68). Assuming a willingness-to-pay (WTP) threshold of 30.000 €/QALY gained, the PSA shows a 81.4% probability for the polypill to be cost-effective and 39.1% chances to be costs saving compared to usual care. In the stroke cohort, the ICER is 386 €/LY and the ICUR is 553 €/QALY. Incremental costs are 34,178 € (polypill, 10,138,807 €; monocomponents: 10,104,629 €) with less subsequent CV events (481.99 vs 564.50) and CV deaths (101.00 vs. 117.23) with the polypill. There is a 75.9% probability for the polypill to be cost-effective and 49.5% chances to be costs saving.
Conclusion
The CV polypill is a cost-effective secondary prevention strategy compared to usual care with monocomponents. Its ICER is well below acceptable thresholds in both CV and cerebrovascular disease patients. It reduces the number of recurrent events at a moderately higher cost compared to monocomponents.
Collapse
Affiliation(s)
- G Rubio
- Ferrer Internacional, Barcelona, Spain
| | - F Araujo
- Hospital Beatriz Angelo, Serviço de Medicina Interna, Loures, Portugal
| | - C Aguiar
- Hospital de Santa Cruz, Serviço de Cardiologia, Carnaxide, Portugal
| | | | | | - S Paz
- Smartwriting4u, Benicassim, Spain
| | - JM Castellano
- National Centre for Cardiovascular Research (CNIC), Madrid, Spain
| |
Collapse
|
7
|
Rubio G, Aguiar C, Araujo F, Carcedo D, Abreu-Oliveira TP, Paz S, Castellano JM. How consistent are cost-effectiveness estimates of a cardiovascular polypill strategy for the secondary prevention of cardiovascular disease across different cardiovascular risk equations? Eur J Prev Cardiol 2021. [DOI: 10.1093/eurjpc/zwab061.446] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Private company. Main funding source(s): Ferre Internacional
Background
Risk equations (RE) are crucial to individualise estimates and properly adjust preventive treatments in patients with previous cardiovascular (CV) disease. RE are also routinely incorporated into health economic assessments but it is unknown if the cost-effectiveness results vary according to the RE applied.
Purpose
To determine the cost-effectiveness of a CV polypill (ASA 100mg, atorvastatin 20/40mg and ramipril 2.5/5/10mg) strategy compared to usual practice of combining monocomponents in the prevention of recurrent events in patients with previous coronary heart disease (CHD) or stroke applying two different CV RE: SMART and FRAMINGHAM, respectively.
Methods
A Markov cost-effectiveness model (1-year cycles; 4 health states: stable disease, subsequent CHD, subsequent stroke; death; payer perspective; direct medical costs; lifetime horizon; 4% discount rate) was developed for Portugal. Transition probability between health states was based on the SMART RE and an adaptation for secondary CV prevention of the FRAMINGHAM RE, respectively. Cost-effectiveness was calculated for a mixed cohort of secondary prevention patients (weighed post-CHD: 57.9%; post-stroke: 42.1%). Systematic literature reviews, Portuguese registries, mortality tables and official reports ware used to identify effectiveness, epidemiological, costs and utility data. Outcomes were costs (€, 2020) per life year (LY) and Quality Adjusted Life Year (QALY) gained. One-way (OWA) and probabilistic (PSA) sensitivity analyses tested the consistency of results. Assumptions were validated by experts.
Results
Applying the SMART RE, the incremental cost-effectiveness ratio (ICER) is 1,555€/LY gained and the incremental cost-utility ratio (ICUR) is 1,785€/QALY gained for the polypill strategy. The incremental costs of adopting the polypill strategy are 171,378€. Recurrent CV events (550.68 vs 642.13) and CV deaths (106.05 vs 122.81) are also less frequent with the polypill strategy compared with monocomponents. Assuming a willingness-to-pay (WTP) threshold of 30.000 €/QALY gained, there is a 77.80% probability for the polypill strategy to be cost-effective and 43.00% chances to be costs saving when used in a mixed cardiovascular and cerebrovascular disease population. Applying the FRAMINGHAM RE, the ICER is 998€/LY gained and the ICUR is 1,242€/QALY. The incremental costs amount 175,122€. Recurrent CV events (452.66 vs 563.48) and CV deaths (104.77 vs 127.32) are less frequent with the polypill strategy. The PSA shows a 99.5% probability for the polypill strategy to be cost-effective and 46.8% chances to be costs saving.
Conclusion
Both risk equations result in comparable results on the cost-effectiveness of interventions for the secondary prevention of CV disease. The polypill strategy remains cost-effective compared to the common practice of using individual monocomponents concomitantly, reducing recurrent CV events at a moderately higher cost.
Collapse
Affiliation(s)
- G Rubio
- Ferrer Internacional, Barcelona, Spain
| | - C Aguiar
- Hospital de Santa Cruz, Serviço de Cardiologia, Carnaxide, Portugal
| | - F Araujo
- Hospital Beatriz Angelo, Serviço de Medicina Interna, Loures, Portugal
| | | | | | - S Paz
- Smartwriting4u, Benicassim, Spain
| | - JM Castellano
- National Centre for Cardiovascular Research (CNIC), Madrid, Spain
| |
Collapse
|
8
|
Dominguez-Centeno I, Jurado-Barba R, Sion A, Martínez-Maldonado A, Castillo-Parra G, López-Muñoz F, Rubio G, Martínez-Gras I. Psychophysiological Correlates of Emotional- and Alcohol-Related Cues Processing in Offspring of Alcohol-Dependent Patients. Alcohol Alcohol 2020; 55:374-381. [PMID: 32300797 DOI: 10.1093/alcalc/agaa006] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2019] [Revised: 09/19/2019] [Accepted: 01/13/2020] [Indexed: 11/13/2022] Open
Abstract
AIMS To determinate if offspring of alcohol-dependent patients (OA) process affective stimuli and alcohol-related cues in a different manner than control subjects do. METHODS Event-related potentials (early posterior negativity [EPN]/ late positive potential [LPP]) and event-related oscillations (Theta) were obtained by electroencephalographic (EEG) recording during the viewing of International Affective Picture System (IAPS) images with positive, negative and neutral valence, as well as alcohol-related cues. The total sample was comprised of 60 participants, divided into two groups: one group consisted of OA (30) and the control group of participants with negative family history of alcohol use disorders (30). RESULTS Theta power analysis implies a significant interaction between condition, region and group factors. Post-hoc analysis indicates an increased theta power for the OA at different regions, during pleasant (frontal, central, parietal, occipital, right temporal); unpleasant (frontal, central, occipital); alcohol (frontal, central, parietal, occipital, right and left temporal) and neutral (occipital) cues. There are no group differences regarding any of the event-related potential measurements (EPN/LPP). CONCLUSIONS There is evidence of alterations in the processing of affective stimuli and alcohol-related information, evidenced by changes in theta brain oscillations. These alterations are characterized by an increased emotional reactivity, evidenced by increased theta at posterior sites. There is also an increased recruitment of emotion control, which could be a compensation mechanism, evidenced by increased theta power at anterior sites during affective stimuli and alcohol cues.
Collapse
Affiliation(s)
- I Dominguez-Centeno
- Department of Psychiatry, Research Institute 12 de Octubre (i+12), Córdoba Ave. n/n, 28041 Madrid, Spain.,Department of Psychology, Faculty of Health Sciences, Camilo José Cela University, 49 Castillo de Alarcon St, Villanueva de la Cañada, 28692 Madrid, Spain
| | - R Jurado-Barba
- Department of Psychiatry, Research Institute 12 de Octubre (i+12), Córdoba Ave. n/n, 28041 Madrid, Spain.,Department of Psychology, Faculty of Health Sciences, Camilo José Cela University, 49 Castillo de Alarcon St, Villanueva de la Cañada, 28692 Madrid, Spain
| | - A Sion
- Department of Psychiatry, Research Institute 12 de Octubre (i+12), Córdoba Ave. n/n, 28041 Madrid, Spain
| | - A Martínez-Maldonado
- Department of Psychiatry, Research Institute 12 de Octubre (i+12), Córdoba Ave. n/n, 28041 Madrid, Spain.,Department of Psychology, Faculty of Health Sciences, Camilo José Cela University, 49 Castillo de Alarcon St, Villanueva de la Cañada, 28692 Madrid, Spain
| | - G Castillo-Parra
- Department of Psychology, Faculty of Health Sciences, Camilo José Cela University, 49 Castillo de Alarcon St, Villanueva de la Cañada, 28692 Madrid, Spain
| | - F López-Muñoz
- Department of Psychiatry, Research Institute 12 de Octubre (i+12), Córdoba Ave. n/n, 28041 Madrid, Spain.,Department of Psychology, Faculty of Health Sciences, Camilo José Cela University, 49 Castillo de Alarcon St, Villanueva de la Cañada, 28692 Madrid, Spain.,Addictive Disorders Network, Health Institute Carlos III, 4 Sinesio Delgado St, 28029 Madrid, Spain
| | - G Rubio
- Department of Psychiatry, Research Institute 12 de Octubre (i+12), Córdoba Ave. n/n, 28041 Madrid, Spain.,Addictive Disorders Network, Health Institute Carlos III, 4 Sinesio Delgado St, 28029 Madrid, Spain.,Psychiatry Department, Faculty of Medicine, Complutense University of Madrid, 2 Séneca Ave., 28040 Madrid, Spain
| | - I Martínez-Gras
- Department of Psychiatry, Research Institute 12 de Octubre (i+12), Córdoba Ave. n/n, 28041 Madrid, Spain.,Addictive Disorders Network, Health Institute Carlos III, 4 Sinesio Delgado St, 28029 Madrid, Spain.,Psychiatry Department, Faculty of Medicine, Complutense University of Madrid, 2 Séneca Ave., 28040 Madrid, Spain
| |
Collapse
|
9
|
Abstract
IntroductionRelapses are common and a higher number of relapses involve a greater cognitive impairment of the patient. Prevention of relapses is therefore the primary objective of treatment.ObjectivesTo establish why a sample of patients with schizophrenia experience relapses and are admitted to acute units as a result.MethodsA multicenter, naturalistic, retrospective study assessing medical intervention in 1346 patients with schizophrenia admitted to acute units in Spain, assessing the following causes of relapses: non-compliance, lack of efficacy, drug abuse, stress and high incidence of side effects.Results90.8% of patients were admitted for relapse. Reasons for admission were non-compliance in 67.1% (77.2% due to lack of insight and 30.59% due to drug abuse), lack of therapeutic efficacy in 27.2%, and drug abuse in 24.3%. In addition, stress and a high incidence of side effects in 5.8% of patients were other reasons for relapse.ConclusionsNon compliance is the main reason for relapses followed by lack of efficacy. The results appear to confirm that drug abuse might influence in a direct (drug abuse itself) or indirect (non compliance because of drug abuse) way in a higher number of relapses.
Collapse
|
10
|
Rodríguez-Jiménez R, Avila C, Ponce G, Ibáñez MI, Rubio G, Jiménez-Arriero MA, Ampuero I, Ramos JA, Hoenicka J, Palomo T. The Taq IA polymorphism linked to the DRD2 gene is related to lower attention and less inhibitory control in alcoholic patients. Eur Psychiatry 2020; 21:66-9. [PMID: 16139486 DOI: 10.1016/j.eurpsy.2005.05.010] [Citation(s) in RCA: 29] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/01/2005] [Accepted: 05/30/2005] [Indexed: 10/25/2022] Open
Abstract
AbstractThe TaqIA polymorphism linked to the DRD2 gene has been associated with alcoholism. The aim of this work is to study attention and inhibitory control as per the continuous performance test and the stop task in a sample of 50 Spanish male alcoholic patients split into two groups according to the presence of the TaqIA1 allele in their genotype. Our results show that alcoholics carrying the TaqIA1 allele present lower sustained attention and less inhibitory control than those patients without such allele.
Collapse
Affiliation(s)
- R Rodríguez-Jiménez
- Unidad de Conductas Adictivas (UCA), Servicio de Psiquiatría, Hospital Universitario 12 de Octubre, Avda. de Córdoba s/n, 28041 Madrid, Spain.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Bobes J, Rubio G, Terán A, Cervera G, López-Gómez V, Vilardaga I, Pérez M. Pregabalin for the discontinuation of long-term benzodiazepines use: An assessment of its effectiveness in daily clinical practice. Eur Psychiatry 2020; 27:301-7. [DOI: 10.1016/j.eurpsy.2010.12.004] [Citation(s) in RCA: 34] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/07/2010] [Revised: 12/15/2010] [Accepted: 12/17/2010] [Indexed: 11/24/2022] Open
Abstract
AbstractPurposeTo evaluate the effectiveness and tolerability of pregabalin in the management of the discontinuation of benzodiazepines in long-term users.Subjects and methodsWe performed a 12-week, prospective, uncontrolled, non-interventional, and observational study in patients aged 18 years old or above, who met DSM-IV-TR criteria for benzodiazepine dependence without other major psychiatry disorder. Evaluations included the Benzodiazepine Withdrawal Symptom Questionnaire, the Hamilton Anxiety Rating Scale, the Clinical Global Impression Scale, and the Sheehan Disability Scale. A urine drug screen for benzodiazepines was performed at baseline and every 4 weeks thereafter. The primary effectiveness variable was success rate, defined as achievement of benzodiazepine-free status at week 12 according to the urine drug screen.Results and discussionThe mean dose at week 12 was 315 (±166) mg/day. The success rate of the benzodiazepine taper in the primary efficacy population (n = 282) was 52% (95% confidence interval [CI], 46–58). Success rates for women and men were 58% (95% CI, 49–67) and 46% (95% CI, 38–55), respectively. The success rates did not differ according to either the benzodiazepine of abuse or the presence of other substance use disorders. Significant and clinically relevant improvements were observed in withdrawal and anxiety symptoms, as well as in patients’ functioning. At week 12, tolerability was rated as good or excellent by 90% and 83% of the clinicians and patients, respectively.ConclusionOur results suggest that pregabalin is an efficacious and well-tolerated adjunctive treatment for benzodiazepine withdrawal.
Collapse
|
12
|
Domínguez-Centeno I, Jurado-Barba R, Sion A, Martinez-Maldonado A, Castillo-Parra G, López-Muñoz F, Rubio G, Martinez-Gras I. P3 Component as a Potential Endophenotype for Control Inhibition in Offspring of Alcoholics. Alcohol Alcohol 2019; 53:699-706. [PMID: 30020398 DOI: 10.1093/alcalc/agy051] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2018] [Accepted: 06/22/2018] [Indexed: 11/14/2022] Open
Abstract
Aims To assess inhibitory processes and the ongoing event-related potential (ERP) activity of offspring of alcoholics (OA) during a Go/No-Go task, with the purpose of characterizing possible psychophysiological endophenotypes for alcohol-dependent vulnerability. Short summary EEG recordings and ERP measurements of young adults with positive and negative family history of alcoholism where obtained while they performed a Go/No-Go task to assess inhibitory processes. Offspring of alcoholics showed a different ERP pattern compared to the control group and exerted greater effort than the control group. Methods ERP measurements were obtained by electroencephalogram (EEG) recordings of 65 participants divided into two groups: one group of 30 subjects with positive family history of alcoholism and a control group of 35 subjects with negative family history of alcoholism. They performed a Go/No-Go task, where each individual was required to classify visual stimuli by colour (Go) and inhibit their response to a No-Go signal. Results OA have higher P3 amplitudes during the Go condition in all of the regions analysed and higher No-Go P3 amplitudes than control subjects in the frontal region. Unlike controls, OA have no differences between the P3 amplitudes across conditions. Conclusions The absence of differences between the P3 Go and No-Go observed in the OA group can be interpreted as a possible alteration related with inhibition, in a way that they may need to recruit similar resources for inhibitory and classificational processes for both conditions. Therefore, the P3 component may be considered as a useful endophenotype and a vulnerability marker to develop addictive behaviour.
Collapse
Affiliation(s)
- I Domínguez-Centeno
- Department of Psychiatry, Research Institute 12 de Octubre (i + 12), Madrid, Spain.,Department of Psychology, Faculty of Health Sciences, Camilo José Cela University, Madrid, Spain
| | - R Jurado-Barba
- Department of Psychiatry, Research Institute 12 de Octubre (i + 12), Madrid, Spain.,Department of Psychology, Faculty of Health Sciences, Camilo José Cela University, Madrid, Spain
| | - A Sion
- Department of Psychiatry, Research Institute 12 de Octubre (i + 12), Madrid, Spain
| | - A Martinez-Maldonado
- Department of Psychiatry, Research Institute 12 de Octubre (i + 12), Madrid, Spain.,Department of Psychology, Faculty of Health Sciences, Camilo José Cela University, Madrid, Spain
| | - G Castillo-Parra
- Department of Psychology, Faculty of Health Sciences, Camilo José Cela University, Madrid, Spain
| | - F López-Muñoz
- Department of Psychiatry, Research Institute 12 de Octubre (i + 12), Madrid, Spain.,Department of Psychology, Faculty of Health Sciences, Camilo José Cela University, Madrid, Spain.,Thematic Network for Cooperative Health Research (RETICS), Addictive Disorders Network, Health Institute Carlos III, MICINN and FEDER, Madrid, Spain
| | - G Rubio
- Department of Psychiatry, Research Institute 12 de Octubre (i + 12), Madrid, Spain.,Psychiatry Department, Faculty of Medicine, UCM, Madrid, Spain.,Thematic Network for Cooperative Health Research (RETICS), Addictive Disorders Network, Health Institute Carlos III, MICINN and FEDER, Madrid, Spain
| | - I Martinez-Gras
- Department of Psychiatry, Research Institute 12 de Octubre (i + 12), Madrid, Spain.,Psychiatry Department, Faculty of Medicine, UCM, Madrid, Spain.,Thematic Network for Cooperative Health Research (RETICS), Addictive Disorders Network, Health Institute Carlos III, MICINN and FEDER, Madrid, Spain
| |
Collapse
|
13
|
Rubio G, Karwowski J, DeAmorim H, Goldstein L, Bornak A. Predicting factors associated with postoperative hypotension following carotid artery stenting. J Vasc Surg 2019. [DOI: 10.1016/j.jvs.2018.10.074] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
14
|
Mourelle R, Pineda F, Ojeda I, Rubio G, Yago A, Baquero D, Ojeda P. Anaphylaxis Caused by Green Tea: A Case Report. J Investig Allergol Clin Immunol 2018; 28:343-344. [DOI: 10.18176/jiaci.0279] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
15
|
Ojeda P, Pineda F, Mourelle R, Rubio G, Yago A, Baquero D, Ojeda I. Thermolability of Soybean Allergen Gly m bd 30K: Report of a Case of Anaphylaxis. J Investig Allergol Clin Immunol 2018; 28:360-362. [PMID: 30350798 DOI: 10.18176/jiaci.0291] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2023] Open
Affiliation(s)
- P Ojeda
- Clinica de Asma y Alergia Dres. Ojeda, Madrid, Spain
| | - F Pineda
- Diater Laboratories, Madrid, Spain
| | - R Mourelle
- Clinica de Asma y Alergia Dres. Ojeda, Madrid, Spain
| | - G Rubio
- Clinica de Asma y Alergia Dres. Ojeda, Madrid, Spain
| | - A Yago
- Clinica de Asma y Alergia Dres. Ojeda, Madrid, Spain
| | - D Baquero
- Clinica de Asma y Alergia Dres. Ojeda, Madrid, Spain
| | - I Ojeda
- Clinica de Asma y Alergia Dres. Ojeda, Madrid, Spain
| |
Collapse
|
16
|
Bellmunt J, Kerst J, Vázquez F, Morales-Barrera R, Grande E, Medina A, González Graguera M, Rubio G, Anido U, Fernández Calvo O, González-Billalabeitia E, Van den Eertwegh A, Pujol E, Perez-Gracia J, González Larriba J, Collado R, Los M, Maciá S, De Wit R. A randomized phase II/III study of cabazitaxel versus vinflunine in metastatic or locally advanced transitional cell carcinoma of the urothelium (SECAVIN). Ann Oncol 2017; 28:1517-1522. [DOI: 10.1093/annonc/mdx186] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2017] [Indexed: 12/17/2022] Open
|
17
|
García-Marchena N, Araos P, Barrios V, Sanchez-Marin L, Chowen J, Ponce G, Argente J, Rubio G, Serrano A, de Fonseca FR, Pavon F. Evaluation of plasma chemokines in patients with alcohol use disorders: Association of CCL11 (Eotaxin-1) with comorbid mental disorders. Alcohol 2017. [DOI: 10.1016/j.alcohol.2017.02.327] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
18
|
Rubio G, Martínez JF, Gómez D, Li X. Semantic Registration and Discovery System of Subsystems and Services within an Interoperable Coordination Platform in Smart Cities. Sensors (Basel) 2016; 16:s16070955. [PMID: 27347965 PMCID: PMC4970009 DOI: 10.3390/s16070955] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 02/05/2016] [Revised: 06/01/2016] [Accepted: 06/17/2016] [Indexed: 06/06/2023]
Abstract
Smart subsystems like traffic, Smart Homes, the Smart Grid, outdoor lighting, etc. are built in many urban areas, each with a set of services that are offered to citizens. These subsystems are managed by self-contained embedded systems. However, coordination and cooperation between them are scarce. An integration of these systems which truly represents a "system of systems" could introduce more benefits, such as allowing the development of new applications and collective optimization. The integration should allow maximum reusability of available services provided by entities (e.g., sensors or Wireless Sensor Networks). Thus, it is of major importance to facilitate the discovery and registration of available services and subsystems in an integrated way. Therefore, an ontology-based and automatic system for subsystem and service registration and discovery is presented. Using this proposed system, heterogeneous subsystems and services could be registered and discovered in a dynamic manner with additional semantic annotations. In this way, users are able to build customized applications across different subsystems by using available services. The proposed system has been fully implemented and a case study is presented to show the usefulness of the proposed method.
Collapse
Affiliation(s)
- Gregorio Rubio
- Centro de Investigación en Tecnologías Software y Sistemas Multimedia para la Sostenibilidad (CITSEM), Universidad Politécnica de Madrid (UPM), Edificio La Arboleda, Campus Sur UPM. Ctra. Valencia, Km 7, 28031 Madrid, Spain.
| | - José Fernán Martínez
- Centro de Investigación en Tecnologías Software y Sistemas Multimedia para la Sostenibilidad (CITSEM), Universidad Politécnica de Madrid (UPM), Edificio La Arboleda, Campus Sur UPM. Ctra. Valencia, Km 7, 28031 Madrid, Spain.
| | - David Gómez
- Centro de Investigación en Tecnologías Software y Sistemas Multimedia para la Sostenibilidad (CITSEM), Universidad Politécnica de Madrid (UPM), Edificio La Arboleda, Campus Sur UPM. Ctra. Valencia, Km 7, 28031 Madrid, Spain.
| | - Xin Li
- Centro de Investigación en Tecnologías Software y Sistemas Multimedia para la Sostenibilidad (CITSEM), Universidad Politécnica de Madrid (UPM), Edificio La Arboleda, Campus Sur UPM. Ctra. Valencia, Km 7, 28031 Madrid, Spain.
| |
Collapse
|
19
|
San L, Arranz B, Dual Pathology Clinical Practice Guide EGF, Arrojo M, Becoña E, Bernardo M, Caballero L, Castells X, Cunill R, Florez G, Franco MD, Garriga M, Goikolea JM, González-Pinto A, Landabaso M, López A, Martinez-Raga J, Merino A, Paramo M, Rubio G, Safont G, Saiz PA, Solà I, Tirado J, Torrens M, Zorrilla I. Clinical guideline for the treatment of dual pathology in the adult population. Adicciones 2016; 28:3-5. [PMID: 26990384 DOI: 10.20882/adicciones.784] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
20
|
Alvarez-Alonso MJ, Jurado-Barba R, Martinez-Martin N, Espin-Jaime JC, Bolaños-Porrero C, Ordoñez-Franco A, Rodriguez-Lopez JA, Lora-Pablos D, de la Cruz-Bértolo J, Jimenez-Arriero MA, Manzanares J, Rubio G. Association between maltreatment and polydrug use among adolescents. Child Abuse Negl 2016; 51:379-89. [PMID: 26318780 DOI: 10.1016/j.chiabu.2015.07.014] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/09/2015] [Revised: 07/14/2015] [Accepted: 07/30/2015] [Indexed: 05/16/2023]
Abstract
Different studies have related sexual and physical abuse during childhood and adolescence to the development of substance abuse disorders. Nevertheless, we are not aware of the role that other more common maltreatment types, such as neglect, will play among the most risky pattern of consumption: the polydrug use. A clinical sample of 655 adolescents, divided into two groups: polydrug users and non-polydrug users, were assessed on their pattern of drug consumption, history of childhood maltreatment, current psychopathology and their family history of alcoholism. Polydrug users had a greater prevalence of all types of maltreatment, although the most associated to this group were sexual abuse and emotional neglect. Other relevant variables to adolescent consumption were: the diagnosis of depressive disorder, the presence of anxiety traits and the family history of alcohol dependence. Polydrug users have higher risks of having had problems during infancy and adolescence, such as maltreatment and other psychopathological conditions, with the addition of family history of alcoholism. Accordingly, practitioners should take into account that those variables may influence polydrug abuse because it is the most risky pattern for subsequent dependence of substances, and they should always be considered during treatment.
Collapse
Affiliation(s)
- M J Alvarez-Alonso
- Hospital 12 de Octubre" i+12 Research Institute, Av. Cordoba s/n, 28041 Madrid, Spain
| | - R Jurado-Barba
- Hospital 12 de Octubre" i+12 Research Institute, Av. Cordoba s/n, 28041 Madrid, Spain; Complutense University, Av. Séneca 2, 28040 Madrid, Spain; Camilo José Cela University, Castillo de Alarcón, 49, Villafranca del Castillo, 28692 Madrid, Spain
| | - N Martinez-Martin
- 12 de Octubre University Hospital, Av. Cordoba s/n, 28041 Madrid, Spain
| | - J C Espin-Jaime
- 12 de Octubre University Hospital, Av. Cordoba s/n, 28041 Madrid, Spain
| | - C Bolaños-Porrero
- Addictions Institute "Madrid Salud", Madrid City Hall, Juan Esplandiú 11, 28007, Spain
| | - A Ordoñez-Franco
- Addictions Institute "Madrid Salud", Madrid City Hall, Juan Esplandiú 11, 28007, Spain
| | - J A Rodriguez-Lopez
- Addictions Institute "Madrid Salud", Madrid City Hall, Juan Esplandiú 11, 28007, Spain
| | - D Lora-Pablos
- Clinical Research Unit, I+12-CIBERESP, Hospital 12 de Octubre, Av. Cordoba s/n, 28041 Madrid, Spain
| | - J de la Cruz-Bértolo
- Clinical Research Unit, I+12-CIBERESP, Hospital 12 de Octubre, Av. Cordoba s/n, 28041 Madrid, Spain
| | - M A Jimenez-Arriero
- Hospital 12 de Octubre" i+12 Research Institute, Av. Cordoba s/n, 28041 Madrid, Spain; Complutense University, Av. Séneca 2, 28040 Madrid, Spain; Clinical Research Unit, I+12-CIBERESP, Hospital 12 de Octubre, Av. Cordoba s/n, 28041 Madrid, Spain; Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Monforte de Lemos 3-5, 28029 Madrid, Spain
| | - J Manzanares
- Networks for Cooperative Research in Health (RETICS-Addictive Disorder Network), Institute of Health Carlos III (ISCIII), MICINN and FEDER, Madrid, Spain; Neurosciences Institute, Universidad Miguel Hernández, Campus San Juan, Alicante, Spain
| | - G Rubio
- Hospital 12 de Octubre" i+12 Research Institute, Av. Cordoba s/n, 28041 Madrid, Spain; Complutense University, Av. Séneca 2, 28040 Madrid, Spain; Clinical Research Unit, I+12-CIBERESP, Hospital 12 de Octubre, Av. Cordoba s/n, 28041 Madrid, Spain; Networks for Cooperative Research in Health (RETICS-Addictive Disorder Network), Institute of Health Carlos III (ISCIII), MICINN and FEDER, Madrid, Spain
| |
Collapse
|
21
|
Arija JA, Pérez-Valderrama B, González-Larriba J, Rodríguez Sánchez A, Chirivella I, Pinto A, Marrero RG, Rubio G, García JJ, Borrega P, Quintela ML, Castellano D, Rodríguez CS, García JM, Lambea-Sorrosal J, Gajate P, Fita MJ, Puertas J, Domínguez RG, Guzmán JV. 2638 Effectiveness of 2nd-line and subsequent therapies after pazopanib (Paz) in patients (pt) with metastatic renal cell carcinoma (mRCC): Final results of the SPAZO study (SOGUG). Eur J Cancer 2015. [DOI: 10.1016/s0959-8049(16)31455-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
22
|
de Fonseca FR, García-Marchena N, Pastor A, Araos P, Pedraz M, Serrano A, Ponce G, Rubio G, Torre RDL, Pavón J. SY21-3PLASMA ACYLETHANOLAMIDES AS BIOMARKERS OF ALCOHOLISM. Alcohol Alcohol 2015. [DOI: 10.1093/alcalc/agv076.88] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
23
|
Rodríguez-Arias M, Navarrete F, Arenas M, Aguilar M, Rubio G, Miñarro J, Manzanares J. SY29-3SOCIAL DEFEAT IN ADOLESCENT MICE INCREASES VULNERABILITY TO ALCOHOL CONSUMPTION. Alcohol Alcohol 2015. [DOI: 10.1093/alcalc/agv076.120] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
24
|
García-Gutiérrez MS, Navarrete F, Aracil-Fernández A, Martínez-Gras I, Lanciego JL, Rubio G, Manzanares J. SY29-2INCREASED VULNERABILITY TO ETHANOL CONSUMPTION IN ADOLESCENT MATERNAL SEPARATED MICE. Alcohol Alcohol 2015. [DOI: 10.1093/alcalc/agv076.119] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
25
|
Li X, Eckert M, Martinez JF, Rubio G. Context Aware Middleware Architectures: Survey and Challenges. Sensors (Basel) 2015; 15:20570-607. [PMID: 26307988 PMCID: PMC4570438 DOI: 10.3390/s150820570] [Citation(s) in RCA: 83] [Impact Index Per Article: 9.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/30/2015] [Revised: 08/12/2015] [Accepted: 08/13/2015] [Indexed: 12/05/2022]
Abstract
Context aware applications, which can adapt their behaviors to changing environments, are attracting more and more attention. To simplify the complexity of developing applications, context aware middleware, which introduces context awareness into the traditional middleware, is highlighted to provide a homogeneous interface involving generic context management solutions. This paper provides a survey of state-of-the-art context aware middleware architectures proposed during the period from 2009 through 2015. First, a preliminary background, such as the principles of context, context awareness, context modelling, and context reasoning, is provided for a comprehensive understanding of context aware middleware. On this basis, an overview of eleven carefully selected middleware architectures is presented and their main features explained. Then, thorough comparisons and analysis of the presented middleware architectures are performed based on technical parameters including architectural style, context abstraction, context reasoning, scalability, fault tolerance, interoperability, service discovery, storage, security & privacy, context awareness level, and cloud-based big data analytics. The analysis shows that there is actually no context aware middleware architecture that complies with all requirements. Finally, challenges are pointed out as open issues for future work.
Collapse
Affiliation(s)
- Xin Li
- Research Center on Software Technologies and Multimedia Systems for Sustainability (CITSEM-Centro de Investigación en Tecnologías Software y Sistemas Multimedia Para la Sostenibilidad), Campus Sur UPM, Ctra. Valencia, Km 7, 28031 Madrid, Spain.
| | - Martina Eckert
- Research Center on Software Technologies and Multimedia Systems for Sustainability (CITSEM-Centro de Investigación en Tecnologías Software y Sistemas Multimedia Para la Sostenibilidad), Campus Sur UPM, Ctra. Valencia, Km 7, 28031 Madrid, Spain.
| | - José-Fernán Martinez
- Research Center on Software Technologies and Multimedia Systems for Sustainability (CITSEM-Centro de Investigación en Tecnologías Software y Sistemas Multimedia Para la Sostenibilidad), Campus Sur UPM, Ctra. Valencia, Km 7, 28031 Madrid, Spain.
| | - Gregorio Rubio
- Research Center on Software Technologies and Multimedia Systems for Sustainability (CITSEM-Centro de Investigación en Tecnologías Software y Sistemas Multimedia Para la Sostenibilidad), Campus Sur UPM, Ctra. Valencia, Km 7, 28031 Madrid, Spain.
| |
Collapse
|
26
|
Marin M, Jurado R, Fernandez Chahill M, Alvarez M, Morales I, Martínez-Gras I, Ponce G, Jimenez-Arriero M, Moratti S, Rubio G. Correlation Between Clinical and Drinking Variables, and Psychophysiological Processes Involved in Alcohol Dependence. Eur Psychiatry 2015. [DOI: 10.1016/s0924-9338(15)31897-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
27
|
Maroto P, Lainez N, Esteban E, Espinosa M, Juan M, Etxaniz O, Suarez C, Sepúlveda J, Rubio G, Arija JA, Jimenez L, Saez M, Puente J, Gonzalez IC, Gallardo E, Jurado J, Garcia-Donas J, Brea ML, Garrido M, Otero DSDPY. Real Life Efficacy and Safety of Axitinib (Axi) in Patients with Renal Cell Carcinoma (Rcc): Results from the Spanish Compassionate Use Program. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu337.42] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
28
|
Abstract
Background Superficial bladder cancer has been the subject of numerous studies for many years, but the evolution of the disease still remains not well understood. After the tumor has been surgically removed, it may reappear at a similar level of malignancy or progress to a higher level. The process may be reasonably modeled by means of a Markov process. However, in order to more completely model the evolution of the disease, this approach is insufficient. The semi-Markov framework allows a more realistic approach, but calculations become frequently intractable. In this context, flowgraph models provide an efficient approach to successfully manage the evolution of superficial bladder carcinoma. Our aim is to test this methodology in this particular case. Results We have built a successful model for a simple but representative case. Conclusion The flowgraph approach is suitable for modeling of superficial bladder cancer.
Collapse
|
29
|
del Puerto-Nevado L, Rojo F, Zazo S, Caramés C, Rubio G, Vega R, Chamizo C, Casado V, Martínez-Useros J, Rincón R, Rodríguez-Remírez M, Borrero-Palacios A, Cristóbal I, Madoz-Gúrpide J, Aguilera O, García-Foncillas J. Active angiogenesis in metastatic renal cell carcinoma predicts clinical benefit to sunitinib-based therapy. Br J Cancer 2014; 110:2700-7. [PMID: 24786599 PMCID: PMC4037833 DOI: 10.1038/bjc.2014.225] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Revised: 02/27/2014] [Accepted: 04/04/2014] [Indexed: 01/15/2023] Open
Abstract
Background: Sunitinib represents a widely used therapy for metastatic renal cell carcinoma patients. Even so, there is a group of patients who show toxicity without clinical benefit. In this work, we have analysed pivotal molecular targets involved in angiogenesis (vascular endothelial growth factor (VEGF)-A, VEGF receptor 2 (KDR), phosphorylated (p)KDR and microvascular density (MVD)) to test their potential value as predictive biomarkers of clinical benefit in sunitinib-treated renal cell carcinoma patients. Methods: Vascular endothelial growth factor-A, KDR and pKDR-Y1775 expression as well as CD31, for MVD visualisation, were determined by immunohistochemistry in 48 renal cell carcinoma patients, including 23 metastatic cases treated with sunitinib. Threshold was defined for each biomarker, and univariate and multivariate analyses for progression-free survival (PFS) and overall survival (OS) were carried out. Results: The HistoScore mean value obtained for VEGF-A was 121.6 (range, 10–300); for KDR 258.5 (range, 150–300); for pKDR-Y1775 10.8 (range, 0–65) and the mean value of CD31-positive structures for MVD visualisation was 49 (range, 10–126). Statistical differences for PFS (P=0.01) and OS (P=0.007) were observed for pKDR-Y1775 in sunitinib-treated patients. Importantly, pKDR-Y1775 expression remained significant after multivariate Cox analysis for PFS (P=0.01; HR: 5.35, 95% CI, 1.49–19.13) and for OS (P=0.02; HR: 5.13, 95% CI, 1.25–21.05). Conclusions: Our results suggest that the expression of phosphorylated (i.e., activated) KDR in tumour stroma might be used as predictive biomarker for the clinical outcome in renal cell carcinoma first-line sunitinib-treated patients.
Collapse
Affiliation(s)
- L del Puerto-Nevado
- Translational Oncology Division, Oncohealth Institute, Health Research Institute FJD-UAM, University Hospital 'Fundación Jiménez Díaz', Avenida Reyes Católicos, 2, 28040 Madrid, Spain
| | - F Rojo
- Department of Pathology, Oncohealth Institute, Health Research Institute FJD-UAM, University Hospital 'Fundación Jiménez Díaz', Avenida Reyes Católicos, 2, 28040 Madrid, Spain
| | - S Zazo
- Department of Pathology, Oncohealth Institute, Health Research Institute FJD-UAM, University Hospital 'Fundación Jiménez Díaz', Avenida Reyes Católicos, 2, 28040 Madrid, Spain
| | - C Caramés
- Translational Oncology Division, Oncohealth Institute, Health Research Institute FJD-UAM, University Hospital 'Fundación Jiménez Díaz', Avenida Reyes Católicos, 2, 28040 Madrid, Spain
| | - G Rubio
- Translational Oncology Division, Oncohealth Institute, Health Research Institute FJD-UAM, University Hospital 'Fundación Jiménez Díaz', Avenida Reyes Católicos, 2, 28040 Madrid, Spain
| | - R Vega
- Department of Pathology, Oncohealth Institute, Health Research Institute FJD-UAM, University Hospital 'Fundación Jiménez Díaz', Avenida Reyes Católicos, 2, 28040 Madrid, Spain
| | - C Chamizo
- Department of Pathology, Oncohealth Institute, Health Research Institute FJD-UAM, University Hospital 'Fundación Jiménez Díaz', Avenida Reyes Católicos, 2, 28040 Madrid, Spain
| | - V Casado
- Translational Oncology Division, Oncohealth Institute, Health Research Institute FJD-UAM, University Hospital 'Fundación Jiménez Díaz', Avenida Reyes Católicos, 2, 28040 Madrid, Spain
| | - J Martínez-Useros
- Translational Oncology Division, Oncohealth Institute, Health Research Institute FJD-UAM, University Hospital 'Fundación Jiménez Díaz', Avenida Reyes Católicos, 2, 28040 Madrid, Spain
| | - R Rincón
- Translational Oncology Division, Oncohealth Institute, Health Research Institute FJD-UAM, University Hospital 'Fundación Jiménez Díaz', Avenida Reyes Católicos, 2, 28040 Madrid, Spain
| | - M Rodríguez-Remírez
- Translational Oncology Division, Oncohealth Institute, Health Research Institute FJD-UAM, University Hospital 'Fundación Jiménez Díaz', Avenida Reyes Católicos, 2, 28040 Madrid, Spain
| | - A Borrero-Palacios
- Translational Oncology Division, Oncohealth Institute, Health Research Institute FJD-UAM, University Hospital 'Fundación Jiménez Díaz', Avenida Reyes Católicos, 2, 28040 Madrid, Spain
| | - I Cristóbal
- Translational Oncology Division, Oncohealth Institute, Health Research Institute FJD-UAM, University Hospital 'Fundación Jiménez Díaz', Avenida Reyes Católicos, 2, 28040 Madrid, Spain
| | - J Madoz-Gúrpide
- Department of Pathology, Oncohealth Institute, Health Research Institute FJD-UAM, University Hospital 'Fundación Jiménez Díaz', Avenida Reyes Católicos, 2, 28040 Madrid, Spain
| | - O Aguilera
- Translational Oncology Division, Oncohealth Institute, Health Research Institute FJD-UAM, University Hospital 'Fundación Jiménez Díaz', Avenida Reyes Católicos, 2, 28040 Madrid, Spain
| | - J García-Foncillas
- Translational Oncology Division, Oncohealth Institute, Health Research Institute FJD-UAM, University Hospital 'Fundación Jiménez Díaz', Avenida Reyes Católicos, 2, 28040 Madrid, Spain
| |
Collapse
|
30
|
Marin M, Rubio G, Jurado R, Ponce G, Martinez I, Alvarez M, Moratti S. EPA-0843 - Relationship between psychophysiological processes involved in alcohol dependence. Eur Psychiatry 2014. [DOI: 10.1016/s0924-9338(14)78180-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
31
|
Petit G, Kornreich C, Noel X, Verbanck P, Campanella S, Choi J, Park SM, Park CB, Gwak AR, Hwang JY, Lee JY, Jung HY, Maurage P, Noel X, Joassin F, Philippot P, Hanak C, Verbank P, Luminet O, de Timary P, Campanella S, Grynberg D, Maurage P, Noel X, Joassin F, Hanak C, Verbank P, Luminet O, de Timary P, Campanella S, Philippot P, Grynberg D, Nyssen L, Quertemont E, Noel X, Doallo S, Gomez-Suarez A, Malkowska A, Topolewska-Wochowska A, Bamburowicz-Klimkowska M, Matsumoto H, Szutowski M, Wojnar M, Corral M, Mateos P, Porras C, Garcia-Moreno LM, Cadaveira F, Rubio G, Libman-Sokolowska M, Matsumoto H, Sygitowicz G, Filipek A, Piwowarska J, Dziklinska A, Radziwon-Zaleska M, Ryszewska-Pokrasniewicz B, Skalski M, Naruszewicz M, Biecek P, Tyce M, Zwierzchowska K, Nasierowski T, Sitkiewicz D, Wojnar M, Kalk N, Cherian R, Naveed M, Newson M, Cavanagh J, Rabiner E, Dar K, McInnes I, Lingford-Hughes A, Neumann A, Vande Weghe N, Philippot P, Luminet O, de Timary P, Vilenne A, Kreusch F, Quertemont E, Brkic S, Soderpalm B, Soderpalm-Gordh A, Oswald L, Wand G, Kuwabara H, Wong D, Brown C, Hutchison KE, Karoly H, Bryan AD, Thayer R, Weiland B, Harlaar N, Bryan AD, Thayer R, Weiland B, Montanaro E, Hutchison K, Lason W, Walecki P, Gorzelanczyk EJ, Walecki P, Gorzelanczyk EJ, Feit J, Pasgreta K, Lason W, Ziolkowski M. PSYCHOLOGY AND MARKERS. Alcohol Alcohol 2013. [DOI: 10.1093/alcalc/agt117] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
32
|
|
33
|
Ojeda PM, Ojeda I, Rubio G, Pineda F. Oleosines in sesame allergy. Clin Transl Allergy 2013. [PMCID: PMC3723685 DOI: 10.1186/2045-7022-3-s3-p170] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
34
|
Ojeda PM, Ojeda I, Rubio G, Pineda F. Oral immunotherapy with raw egg: immunological data at 6 and 18 months. Clin Transl Allergy 2013. [PMCID: PMC3723965 DOI: 10.1186/2045-7022-3-s3-p18] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/02/2022] Open
|
35
|
de Ory F, Avellón A, Echevarría JE, Sánchez-Seco MP, Trallero G, Cabrerizo M, Casas I, Pozo F, Fedele G, Vicente D, Pena MJ, Moreno A, Niubo J, Rabella N, Rubio G, Pérez-Ruiz M, Rodríguez-Iglesias M, Gimeno C, Eiros JM, Melón S, Blasco M, López-Miragaya I, Varela E, Martinez-Sapiña A, Rodríguez G, Marcos MÁ, Gegúndez MI, Cilla G, Gabilondo I, Navarro JM, Torres J, Aznar C, Castellanos A, Guisasola ME, Negredo AI, Tenorio A, Vázquez-Morón S. Viral infections of the central nervous system in Spain: a prospective study. J Med Virol 2012; 85:554-62. [PMID: 23239485 DOI: 10.1002/jmv.23470] [Citation(s) in RCA: 118] [Impact Index Per Article: 9.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/12/2012] [Indexed: 11/10/2022]
Abstract
The aim of the study was to determine the incidence of viruses causing aseptic meningitis, meningoencephalitis, and encephalitis in Spain. This was a prospective study, in collaboration with 17 Spanish hospitals, including 581 cases (CSF from all and sera from 280): meningitis (340), meningoencephalitis (91), encephalitis (76), febrile syndrome (7), other neurological disorders (32), and 35 cases without clinical information. CSF were assayed by PCR for enterovirus (EV), herpesvirus (herpes simplex [HSV], varicella-zoster [VZV], cytomegalovirus [CMV], Epstein-Barr [EBV], and human herpes virus-6 [HHV-6]), mumps (MV), Toscana virus (TOSV), adenovirus (HAdV), lymphocytic choriomeningitis virus (LCMV), West Nile virus (WNV), and rabies. Serology was undertaken when methodology was available. Amongst meningitis cases, 57.1% were characterized; EV was the most frequent (76.8%), followed by VZV (10.3%) and HSV (3.1%; HSV-1: 1.6%; HSV-2: 1.0%, HSV non-typed: 0.5%). Cases due to CMV, EBV, HHV-6, MV, TOSV, HAdV, and LCMV were also detected. For meningoencephalitis, 40.7% of cases were diagnosed, HSV-1 (43.2%) and VZV (27.0%) being the most frequent agents, while cases associated with HSV-2, EV, CMV, MV, and LCMV were also detected. For encephalitis, 27.6% of cases were caused by HSV-1 (71.4%), VZV (19.1%), or EV (9.5%). Other positive neurological syndromes included cerebellitis (EV and HAdV), seizures (HSV), demyelinating disease (HSV-1 and HHV-6), myelopathy (VZV), and polyradiculoneuritis (HSV). No rabies or WNV cases were identified. EVs are the most frequent cause of meningitis, as is HSV for meningoencephalitis and encephalitis. A significant number of cases (42.9% meningitis, 59.3% meningoencephalitis, 72.4% encephalitis) still have no etiological diagnosis.
Collapse
Affiliation(s)
- F de Ory
- National Centre for Microbiology, Majadahonda, Spain.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
36
|
Irastorza LJ, Rojano P, Gonzalez-Salvador T, Cotobal J, Leira M, Rojas C, Rubio G, Rodríguez-Rieiro C, Bellon JM, Alvarez M, Rodríguez C, Arango C. Psychometric properties of the Spanish version of the diagnostic interview for depressive personality. Eur Psychiatry 2012; 27:582-90. [PMID: 21296561 DOI: 10.1016/j.eurpsy.2010.11.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/01/2010] [Revised: 11/15/2010] [Accepted: 11/16/2010] [Indexed: 10/18/2022] Open
Abstract
The aim of this study was to evaluate the reliability and validity of the Spanish-language version of the diagnostic interview for depressive personality (DIDP). The DIDP was administered to 328 consecutive outpatients and the test-retest and inter-rater reliability were assessed. Factor analysis was used in search of factors capable of explaining the scale and a cutoff point was established. The DIDP scales showed adequate Cronbach's α values and acceptable test-retest and inter-rater reliability coefficients. Convergent and discriminant validity were explored, the latter with respect to avoidant and borderline personality disorders. The results of the factor analysis were consistent with the four-factor structure of the DIDP scales. The receiver operating characteristic (ROC) analysis revealed the area under the curve to be 0.848. We found 30 to be a good cutoff point, with a sensitivity of 74.5% and a specificity of 78.5%. The DIDP proved to be a reliable and valid instrument for assessing depressive personality disorder, at least among our outpatients. The psychometric properties of the DIDP support its clinical usefulness in assessing depressive personality.
Collapse
Affiliation(s)
- L J Irastorza
- Mental Health Centre, Arganda del Rey, Hospital Virgen de la Torre, 28500 Madrid, Spain.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
37
|
Rubio G, Jiménez-Arriero MA, Ponce G, Palomo T. Naltrexone Versus Acamprosate: One Year Follow-Up Of Alcohol Dependence Treatment. Alcohol Alcohol 2012. [DOI: 10.1093/alcalc/ags114] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
38
|
Domine M, Rojo F, Izarzugaza Y, Zazo S, Lobo F, Aceñero MF, Madoz J, Casado V, Rubio G, Garcia-Foncillas J. Kras Status as Predictive Marker of Response and Time to Progression in EGFR Wild-Type Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Patients Treated with Platin-Docetaxel-Bevacizumab. Ann Oncol 2012. [DOI: 10.1016/s0923-7534(20)32758-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
39
|
López-Muñoz F, Rubio G, Molina J, Alamo C. La glándula pineal como instrumento físico de las facultades del alma: una conexión histórica persistente. Neurologia 2012; 27:161-8. [DOI: 10.1016/j.nrl.2011.04.018] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2011] [Revised: 04/14/2011] [Accepted: 04/24/2011] [Indexed: 11/27/2022] Open
|
40
|
Jurado-Barba R, Morales-Muñoz I, Rodríguez-Jiménez R, Caballero M, Martín-Loeches M, Casado P, Molina V, Rubio G. P-368 - Impairments in P3a and P3b subcomponents in patients with first early psychosis. Eur Psychiatry 2012. [DOI: 10.1016/s0924-9338(12)74535-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
41
|
Martinez-Gras I, Garcia-Sanchez F, Guaza C, Rodriguez-Jimenez R, Andres-Esteban E, Palomo T, Rubio G, Borrel J. P-1270 - Cytokines levels in schizophrenia patients and in theirs first- degree biological relatives. Eur Psychiatry 2012. [DOI: 10.1016/s0924-9338(12)75437-8] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
42
|
Rubio G, Marin M, Martínez-Gras I, Ponce G, Moratti S. P-60 - Chronic cocaine use increases alcohol-cue appetitiveness in subjects with and without alcohol dependence. Eur Psychiatry 2012. [DOI: 10.1016/s0924-9338(12)74227-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
|
43
|
Tiihonen J, Lopez-Munoz F, Rubio G. Many people show poor adherence to their initial antipsychotic after first hospitalisation with schizophrenia. Evidence-Based Mental Health 2011; 14:96. [DOI: 10.1136/ebmh.2011.100155] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
44
|
López-Muñoz F, Molina J, Rubio G, Alamo C. An historical view of the pineal gland and mental disorders. J Clin Neurosci 2011; 18:1028-37. [DOI: 10.1016/j.jocn.2010.11.037] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/25/2010] [Revised: 11/04/2010] [Accepted: 11/06/2010] [Indexed: 11/29/2022]
|
45
|
Castillo O, Campos R, Vidal I, Fonerón A, Rubio G, Landerer E, Gómez R. Cistectomía radical laparoscópica con confección extracorpórea de neovejiga ortotópica ileal en forma de "Y" usando sutura mecánica no reabsorbible (Fontana). Actas Urol Esp 2011. [DOI: 10.4321/s0210-48062011000500008] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
46
|
Castillo O, Campos R, Vidal I, Fonerón A, Rubio G, Landerer E, Gómez R. [Laparoscopic radical cystectomy with extracorporeal creation of a "Y" shaped orthotopic ileal neobladder using non-reabsorbable mechanical suture (Fontana)]. Actas Urol Esp 2011; 35:296-301. [PMID: 21419518 DOI: 10.1016/j.acuro.2010.11.018] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/24/2010] [Accepted: 11/04/2010] [Indexed: 10/26/2022]
Abstract
INTRODUCTION We describe the technique and present the preliminary results of the laparoscopic radical cystectomy technique with the extracorporeal creation of a "y" shaped ileal orthotopic neobladder using non-absorbable mechanical suture (Fontana). MATERIALS AND METHOD We describe the technique step by step and we present a series of 15 patients that underwent this surgery between November 2005 and August 2009, with special emphasis on the duration of the surgery, urinary diversion time, intraoperative and postoperative complications, daytime and night time continence and the frequency of postoperative micturition. RESULTS The mean follow-up of the series was 24 months (6-32). The mean duration of surgery was 280 (range 210-345) minutes and the mean urinary diversion time was 54.5 (range 40-75) minutes. There were no intraoperative complications and the average hospitalization time was 7 (range 5-15) days. During the follow-up, there were 5 late postoperative complications, 2 cases of urinary infection with good response to antibiotic treatment and 3 uretero-neovesical anastomosis strictures, which were treated with percutaneous balloon dilation, with a good functional result. No lithiasis was found in the neobladder. Complete daytime continence was obtained in 13/14 patients (92.9%) and complete night time continence in 6/14 (42.9%). One patient (6.7%) required clean intermittent self-catheterization as the patient did not micturate spontaneously. CONCLUSIONS The creation of a "Y" shaped ileal orthotopic neobladder using non-absorbable mechanical suture is a feasible, fast and safe technique and it provides promising functional results. Further follow-up is required to determine its long-term results.
Collapse
|
47
|
San-Molina L, Rubio G, Bernardo-Fernández I, Miguélez-Fernández S. Clinical improvement at Day 3 as factor influencing length of hospital stay and discharge of patients with schizophrenia. Eur Psychiatry 2011. [DOI: 10.1016/s0924-9338(11)73053-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
Abstract
IntroductionThe type of treatment used for patients with schizophrenia and an improvement at Day 3 can affect the length of stay and symptom outcome.ObjectivesTo determine the influence of improvement at Day 3 in the lenght of hospital stay and hospital discharge in the case of patients with schizophrenia admitted to acute units.MethodsA multicenter, naturalistic, retrospective study evaluating medical intervention in 1346 patients with schizophrenia in acute units in Spain.ResultsThe mean of hospital stay days was 23.3 (range 1–260 days). 49.5% of patients with improvement at Day 3 had a shorter length of hospital stay. 78.7% received treatment with antipsychotics prior to admission. The most common drugs were risperidone, olanzapine and quetiapine. 99.8% and 99.7% were treated during hospital stay and on discharge, respectively. The drugs most commonly used were paliperidone ER, risperidone and olanzapine. 99.8% of patients with improvement measured by GCI at Day 3 and 100% with improvement at Day 5 had improved at discharge. The percentage of patients requiring use of benzodiazepines or physical/mechanical restriction decreased as the days passed.ConclusionsThe three most commonly used drugs during admission were effective, but the action of paliperidone ER is to be noted (its use increased from 4% prior to admission to 43% and 44% during hospital stay and on discharge, respectively). The results of this study appear to confirm that symptom improvement should be obtained as early as the first week of treatment to achieve a shorter hospital stay.
Collapse
|
48
|
San-Molina L, Rubio G, Bernardo-Fernández I, Miguélez-Fernández S. Correlation between clinical outcome in the first 5 Days of treatment and on hospital discharge in patients with schizophrenia. Eur Psychiatry 2011. [DOI: 10.1016/s0924-9338(11)73055-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
Abstract
IntroductionIn patients with acute clinical symptoms, a short hospital stay and prevalent therapeutic objectives aimed at controlling symptoms overcome the clinician's concern for the functionality levels that will be even more significant after discharge.ObjectivesTo establish the clinical condition of patients admitted to acute/short-stay units in the first five days of hospital stay and on hospital discharge.MethodsA multicenter, naturalistic, retrospective, observational study to evaluate clinical assessment (CGI) obtained in patients with schizophrenia after treatment at the time of admission and on hospital discharge.ResultsThe mean score of the CGI questionnaire decreases from 5.3 recorded on admission to 4.3 on Day 5 and 3 on discharge. On Day 5 of hospital stay, symptoms had improved in 57.3% of cases. In 30.9% of cases there were no changes and in 1.7% symptoms had worsened. In 86.3% of patients symptoms had improved at discharge. 100% of patients with clinical improvement at Day 5 had a clinically significant improvement on hospital discharge.ConclusionsClinical improvement in the first five days after hospital admission appears to lead to a better clinical prognosis on hospital discharge. Hospital discharge should be scheduled from admission, so treatment choice should be geared to looking to control symptoms in the first few days and allow for better social and personal functioning after discharge.
Collapse
|
49
|
Parra C, Gómez R, Marchetti P, Rubio G, Felmer A, Castillo OA. [Management of hemorrhagic radiation cystitis with hyperbaric oxygen therapy]. Actas Urol Esp 2011; 35:175-9. [PMID: 21334100 DOI: 10.1016/j.acuro.2010.09.006] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2010] [Accepted: 09/18/2010] [Indexed: 11/18/2022]
Abstract
INTRODUCTION AND OBJECTIVES hemorrhagic cystitis (HC) after pelvic radiotherapy occurs in 2-8% of patients. A variety of treatments have been described, most of them with uncertain results. We assessed the efficacy of hyperbaric oxygen therapy (HBOT) in HC cases. PATIENTS AND METHODS retrospective analysis of patients with HC after pelvic radiotherapy receiving HBOT at our center between January 2002 and January 2010. Our protocol included 40 sessions of HBOT in a multiplace hyperbaric chamber with 90minutes of 100% oxygen breathing at 2.2 atm. Success was evaluated in terms of total or partial stop of bladder bleeding. Telephone follow-up was updated at the time of submission in all cases. RESULTS twenty-five patients were treated (21 male, 4 female); the mean age was 66.7 years. Twenty men were irradiated for prostate cancer and one for bladder cancer. Three women had cervix cancer and one endometrial cancer. In all cases previous conservative treatment had failed and HBOT was considered only after other measures failed. All the patients responded to HBOT and none recurred after end of treatment at a mean follow-up of 21.2 months. There were no serious complications. CONCLUSION HBOT is a highly effective and safe, non-invasive therapy for HC secondary to pelvic radiation; it should be considered as first line alternative in these difficult cases.
Collapse
Affiliation(s)
- C Parra
- Servicio de Urología Facultad de Medicina, Universidad Andrés Bello, Santiago, Chile
| | | | | | | | | | | |
Collapse
|
50
|
Parra C, Gómez R, Marchetti P, Rubio G, Felmer A, Castillo O. Tratamiento de la cistitis actínica hemorrágica mediante oxigenoterapia hiperbárica. Actas Urol Esp 2011. [DOI: 10.4321/s0210-48062011000300011] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|